FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Conrad Baldamus

Research Profile

Procedures

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Phenomena

Hematocrit

Co-author Network

Publications

TOP 3
Volker R Burst; Meyke Gillis; Florian Pütsch; Ruth Herzog; Jürgen H Fischer; Petra Heid; Jochen Müller-Ehmsen; Kerstin Schenk; Jochen W U Fries; Conrad A Baldamus; Thomas Benzing
Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury.
Markus P Stoffel; Heinz Haverkamp; Arno Kromminga; Karl Wilhelm Lauterbach; Conrad A Baldamus
Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
Fülöp Scheibler; Markus P Stoffel; Claudia Barth; Christine Kuch; Petra Steffen; Conrad A Baldamus; Holger Pfaff
[Shared decision-making as a new quality indicator in nephrology: a nationwide survey in Germany].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Conrad Baldamus (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Volker R Burst; Meyke Gillis; Florian Pütsch; Ruth Herzog; Jürgen H Fischer; Petra Heid; Jochen Müller-Ehmsen; Kerstin Schenk; Jochen W U Fries; Conrad A Baldamus; Thomas Benzing
Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury.
Nephron. Experimental nephrology 2010;114(3):e107-16.
2007: Markus P Stoffel; Heinz Haverkamp; Arno Kromminga; Karl Wilhelm Lauterbach; Conrad A Baldamus
Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
Nephron. Clinical practice 2007;105(2):c90-8.
2005: Fülöp Scheibler; Markus P Stoffel; Claudia Barth; Christine Kuch; Petra Steffen; Conrad A Baldamus; Holger Pfaff
[Shared decision-making as a new quality indicator in nephrology: a nationwide survey in Germany].
Medizinische Klinik (Munich, Germany : 1983) 2005;100(4):193-9.
2004: Markus P Stoffel; Karl Wilhelm Lauterbach; Conrad A Baldamus
[Guideline-based medical quality management in dialysis. Motivation and structuring of a quality-management system and integration of earlier disease stages of chronic renal failure].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2004;98(7):609-16.
2004: Markus P Stoffel; Claudia Barth; Karl Wilhelm Lauterbach; Conrad A Baldamus
Evidence-based medical quality management in dialysis--Part II: Improvement of hemodialysis adequacy.
Clinical nephrology 2004;62(3):219-25.
2004: Markus P Stoffel; Claudia Barth; Karl Wilhelm Lauterbach; Conrad A Baldamus
Evidence-based medical quality management in dialysis--Part I: Routine implementation of QiN, a German quality management system.
Clinical nephrology 2004;62(3):208-18.
2003: Matthias T F Wolf; Bettina Mucha; Massimo Attanasio; Isabella Zalewski; Stephanie M Karle; Hartmut P H Neumann; Nazneen Rahman; Birgit Bader; Conrad A Baldamus; Edgar Otto; Ralph Witzgall; Arno Fuchshuber; Friedhelm Hildebrandt
Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains.
Kidney international 2003;64(5):1580-7.
2002: Francesco Locatelli; Conrad A Baldamus; Giuseppe Villa; Alexandru Ganea; Angel L Martín de Francisco
Once-weekly compared with three-times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(1):119-25.
2002: Francesco Locatelli; Conrad A Baldamus; Giuseppe Villa; A Ganea; A M De Francisco
A rationale for an individualized administration frequency of epoetin beta: a pharmacological perspective.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 6():13-6.
2001: Markus P Stoffel; M Pollok; J Fries; Conrad A Baldamus
Radiation nephropathy after radiotherapy in metastatic medullary thyroid carcinoma.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(5):1082-3.
2001: Claudia Barth; U Diening; J Stachowski; S Jacob; R Herzog; Conrad A Baldamus
Survival- and apoptosis-inducing genes of the BCL-2 gene family expressed in urine lymphocytes to monitor renal transplant function.
Transplantation proceedings 2001;33(1-2):255.
2000: J Stachowski; C Barth; J Michałkiewicz; Tomasz Krynicki; T Jarmoliński; Dariusz Runowski; Maria Lewandowska-Stachowiak; Marcin Zaniew; Alfred Warzywoda; E Bortkiewicz; M Dobosz; Janusz Maciejewski; Conrad A Baldamus
Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome.
Pediatric nephrology (Berlin, Germany) 2000;14(8-9):779-85.
2000: Markus P Stoffel; M Pollok; Conrad A Baldamus
Troponin I is a better prognostic parameter of cardiovascular events in asymptomatic patients on haemodialysis than troponin T.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(8):1259-60.
2000: TA Marsen; F Weber; G Egink; G Suckau; Conrad A Baldamus
Differential transcriptional regulation of endothelin-1 by immunosuppressants FK506 and cyclosporin A.
Fundamental & clinical pharmacology 2000;14(4):401-8.
2000: J Stachowski; C B Zanker; Dariusz Runowski; Marcin Zaniew; A Peszko; A Medyńska; D Zwolińska; A Rogowska-Kalisz; L Hyla-Klekot; K Szprygner; J Weglarska; Maria Sieniawska; W Musiał; Janusz Maciejewski; Conrad A Baldamus
[Resistance to therapy in primary nephrotic syndrome: effect of MDR1 gene activity].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2000;8(46):218-21.
2000: TA Marsen; G Sukau; M Pollok; Conrad A Baldamus
Enalapril and losartan augment endogenous nitric oxide release in Takayasu's arteritis--a case report.
Angiology 2000;51(1):69-75.
1999: TA Marsen; G Egink; G Suckau; Conrad A Baldamus
Tyrosine-kinase-dependent regulation of the nitric oxide synthase gene by endothelin-1 in human endothelial cells.
Pflügers Archiv : European journal of physiology 1999;438(4):538-44.
1999: TA Marsen; F Weber; G Egink; G Suckau; Conrad A Baldamus
Cyclosporin A induces prepro endothelin-1 gene transcription in human endothelial cells.
European journal of pharmacology 1999;379(1):97-106.
1998: Markus P Stoffel; Hans Michael Steffen; Volker Dries; Hans P Dienes; Conrad A Baldamus
Acute exacerbation of overlapping autoimmune liver disease with development of giant cell hepatitis after 14 years' disease duration.
Journal of internal medicine 1998;244(4):355-60.
1998: Claudia Barth; E Rodermann; J Stachowski; R Herzog; S Rohde; Conrad A Baldamus
Expression of granzyme B, perforin and TIA-1 in urine lymphocytes: noninvasive monitoring of renal transplant function.
Transplantation proceedings 1998;30(5):2347.
1998: Markus P Stoffel; M Pollok; Harald Seifert; Conrad A Baldamus
Systemic infection with Yersinia enterocolitica in a hemodialysis patient.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1998;287(4):485-7.
1998: J Stachowski; Claudia Barth; Maria Lewandowska-Stachowiak; P Lammerding; Dariusz Runowski; Conrad A Baldamus
Flow cytometric analysis of urine lymphocytes isolated from patients with renal transplants--purification of urine lymphocytes.
Journal of immunological methods 1998;213(2):145-55.
1998: Claudia Barth; J Stachowski; A von Menges; P Lammerding; Conrad A Baldamus
[Immunologic, alloantigen-dependent factors in chronic graft rejection].
Medizinische Klinik (Munich, Germany : 1983) 1998;93(1):1-5.
1998: C Schmitt; K Ciré; S Schattenkirchner; M Pollok; Conrad A Baldamus; B Krug; T Kirchner; P H Wünsch; T Krieg; Michael Staak
Highly sensitive DNA typing for detecting tumors transmitted by transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11(5):382-6.
1997: Claudia Barth; J Stachowski; A von Menges; E Rodermann; M Pollok; H Smola; T Krieg; Conrad A Baldamus
Limited T-cell repertoire in renal allograft and allogeneic melanoma transmitted by the graft.
Transplantation 1997;64(11):1627-30.
1997: J Kramer; J Stachowski; C Barth; E Ujhelyi; V Tarján; W Sulowicz; George Füst; Conrad A Baldamus
Genetic regulation of the impaired immune response to hepatitis-B vaccine associated with low TCR density in end stage renal disease patients: contribution of complement C4 and factor B alleles.
Immunology letters 1997;59(1):13-9.
1997: B Zanker; Claudia Barth; J Stachowski; Conrad A Baldamus; Walter Land
Multidrug resistance gene MDR1 expression: a gene transfection in vitro model and clinical analysis in cyclosporine-treated patients rejecting their renal grafts.
Transplantation proceedings 1997;29(1-2):1507-8.
1996: F Dellanna; A Wuepper; Conrad A Baldamus
Internal filtration--advantage in haemodialysis?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 2():83-6.
1995: J Stachowski; J Kramer; George Füst; Janusz Maciejewski; Conrad A Baldamus; G G Petrányi
Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients.
Scandinavian journal of immunology 1995;42(1):60-5.
1995: B Zanker; C Barth; A V Menges; P Lammerding; J Stachowski; Conrad A Baldamus
Expression of the multidrug resistance gene MDR-1 in peripheral blood mononuclear cells from cyclosporine-treated renal transplant recipients rejecting their graft.
Transplantation proceedings 1995;27(1):925-6.
1995: J Stachowski; Dariusz Runowski; J Kramer; K Madaliński; Janusz Maciejewski; Conrad A Baldamus
[Reactivity to hepatitis B vaccination (HBV) in patients with uremia: association with defined HLA antigen configuration and complement protein allotypes C4A, C4B and B factor (Bf)].
Przegla̧d lekarski 1995;52(9):445-54.
1994: J Stachowski; M Pollok; C Barth; Janusz Maciejewski; Conrad A Baldamus
Non-responsiveness to hepatitis B vaccination in haemodialysis patients: association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(2):144-52.
1993: P Wienand; J Isenberg; Dirk L Stippel; T Schröder; Conrad A Baldamus
Cyclosporin A: early or delayed onset by prophylactic immunosuppression?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1993;8(4):366-8.
1993: J Stachowski; M Pollok; H Burrichter; C Spithaler; Conrad A Baldamus
Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number.
Nephron 1993;64(3):369-75.
1992: TA Marsen; M Pollok; K Oette; Conrad A Baldamus
Pharmacokinetics of omega-3-fatty acids during ingestion of fish oil preparations.
Prostaglandins, leukotrienes, and essential fatty acids 1992;46(3):191-6.
1992: TA Marsen; M Pollok; Conrad A Baldamus
[Erythropoietin: from established therapeutic procedures in renal anemia to future areas of use].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(4):207-14.
1992: U J Hesse; P Wienand; Conrad A Baldamus; M Pollok; H Pichlmaier
The risk of infection following OKT3 and antilymphocyte globulin treatment for renal transplant rejection: results of a single center prospectively randomized trial.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S440-3.
1992: P Wienand; T Schröder; Dirk L Stippel; Conrad A Baldamus
Donor conditions and graft survival--a retrospective study.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S151-2.
1992: Dirk L Stippel; P Wienand; N Weissenberg; Conrad A Baldamus; U Kruppenbacher
CMV prophylaxis after renal transplantation with immunoglobulin or CMV-hyperimmunoglobulin--a prospective clinical trial.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S146-7.
1992: P Wienand; T Schröder; Conrad A Baldamus
Early or delayed onset of cyclosporine by sequential immunosuppression?
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S121-2.
1991: R Müller; H M Steffen; Richard Brunner; J Saric; M Pollok; Conrad A Baldamus; W Kaufmann
Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
Clinical and investigative medicine. Médecine clinique et experimentale 1991;14(6):614-22.
1991: R Müller; H M Steffen; Richard Brunner; M Pollok; Conrad A Baldamus; W Kaufmann
[Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
Klinische Wochenschrift 1991;69(16):742-8.
1991: P Wienand; T Schröder; Dirk L Stippel; Conrad A Baldamus
Which donor factors have an influence on recipient and graft survival? Retrospective analysis of 308 renal transplants at a single centre.
Transplantation proceedings 1991;23(5):2560-2.
1991: J Stachowski; M Pollok; H Burrichter; C Spithaler; Conrad A Baldamus
Does uremic environment down-regulate T cell activation via TCR/CD3 antigen receptor complex?
Journal of clinical & laboratory immunology 1991;36(1):15-21.
1991: J Stachowski; M Pollok; H Burrichter; Conrad A Baldamus
Immunodeficiency in ESRD-patients is linked to altered IL-2 receptor density on T cell subsets.
Journal of clinical & laboratory immunology 1991;34(4):171-7.
1991: Céline Granolleras; B Branger; stanley shaldon; B Nonnast-Daniel; Karl-Martin Koch; M Pollok; Conrad A Baldamus
Subcutaneous erythropoietin: a comparison of daily and thrice weekly administration.
Contributions to nephrology 1991;88():144-8; discussion 149-51.
1990: U J Hesse; P Wienand; Conrad A Baldamus; W Arns
Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative period.
Transplantation proceedings 1990;22(5):2273-4.
1990: Conrad A Baldamus; A M Steffen; Richard Brunner; M Pollok
Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
Contributions to nephrology 1990;82():79-85.
1989: Paul Steinfeld; M Pollok; Conrad A Baldamus
[Erythropoietin as a therapeutic agent. II: Indications, side effects and dangers].
Medizinische Klinik (Munich, Germany : 1983) 1989;84(4):216-8.
1989: Paul Steinfeld; M Pollok; Conrad A Baldamus
[Erythropoietin as a therapeutic agent. I: Development and properties].
Medizinische Klinik (Munich, Germany : 1983) 1989;84(3):160-4.
1989: TA Marsen; R Hönig; S Schad; C Barth; M Pollok; Conrad A Baldamus
How to interpret intratreatment changes in plasma beta-2-microglobulin concentrations.
Contributions to nephrology 1989;74():147-52.
1989: M Pollok; J Bommer; H J Gurland; Karl-Martin Koch; W Schoeppe; P Scigalla; Conrad A Baldamus
Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study.
Contributions to nephrology 1989;76():201-11; discussion 212-8.
1989: Walter Samtleben; Conrad A Baldamus; J Bommer; P Grützmacher; B Nonnast-Daniel; P Scigalla; H J Gurland
Indications and contraindications for recombinant human erythropoietin treatment. Results in hemodialysis patients.
Contributions to nephrology 1989;76():193-200; discussion 212-8.
1989: J Bommer; W Samtleben; K M Koch; Conrad A Baldamus; P Grützmacher; P Scigalla
Variations of recombinant human erythropoietin application in hemodialysis patients.
Contributions to nephrology 1989;76():149-56; discussion 156-8.
1989: Richard Brunner; M Pollok; M Heidel; R Müller; S Degenhardt; Conrad A Baldamus
Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
Contributions to nephrology 1989;76():306-12; discussion 312-4.
1989: H M Steffen; Richard Brunner; R Müller; S Degenhardt; M Pollok; R Lang; Conrad A Baldamus
Peripheral hemodynamics, blood viscosity, and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin.
Contributions to nephrology 1989;76():292-8.
1988: R Hönig; TA Marsen; S Schad; C Barth; M Pollok; Conrad A Baldamus
Correlation of beta-2-microglobulin concentration changes to changes of distribution volume.
The International journal of artificial organs 1988;11(6):459-64.
1988: D J Ziegenhagen; G Crombach; M Dieckmann; E Zehnter; P Wienand; Conrad A Baldamus
[Pregnancy during cyclosporin medication following a kidney transplant].
Deutsche medizinische Wochenschrift (1946) 1988;113(7):260-3.
1988: W Waters; U Wellner; Conrad A Baldamus; P Bramsiepe; Harald Schicha
Effect of erythropoietin on iron kinetics in patients with end-stage renal disease.
Contributions to nephrology 1988;66():156-64.
1988: E Zehnter; M Pollok; D Ziegenhagen; P Bramsiepe; F Longere; Conrad A Baldamus; U Wellner; W Waters
Urea kinetics in patients on regular dialysis treatment before and after treatment with recombinant human erythropoietin.
Contributions to nephrology 1988;66():149-55.
1988: K Kühn; B Nonnast-Daniel; P Grützmacher; J Grüner; W Pfåffl; Conrad A Baldamus; P Scigalla
Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
Contributions to nephrology 1988;66():94-103.
1988: Walter Samtleben; Conrad A Baldamus; J Bommer; Winfried Fassbinder; B Nonnast-Daniel; H J Gurland
Blood pressure changes during treatment with recombinant human erythropoietin.
Contributions to nephrology 1988;66():114-22.
1987: R Grundmann; U Hesse; P Wienand; Conrad A Baldamus; W Arns
Graft survival and long-term renal function after sequential conventional cyclosporin A therapy in cadaver kidney transplantation--a prospective randomized trial.
Klinische Wochenschrift 1987;65(18):879-84.
1987: R Grundmann; P Wienand; A Runde; Conrad A Baldamus; W Arns; U Burkhardt
[Cytomegalovirus hyperimmunoglobulin prophylaxis following kidney transplantation. Results of a prospective randomized study].
Deutsche medizinische Wochenschrift (1946) 1987;112(21):827-31.
1986: P Grützmacher; Ernst-Heinrich Scheuermann; W Siede; P D Lang; U Abshagen; H W Radtke; Conrad A Baldamus; W Schoeppe
Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects.
Klinische Wochenschrift 1986;64(19):910-6.
1985: Conrad A Baldamus; H Schmidt; Ernst-Heinrich Scheuermann; E Werner; Joachim Peter Kaltwasser; W Schoeppe
Desferrioxamine treatment for aluminium and iron overload in uraemic patients by haemodialysis or haemofiltration.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress 1985;21():382-6.
1983: Ernst-Heinrich Scheuermann; Winfried Fassbinder; U Frei; K M Koch; Conrad A Baldamus
Eosinophilia in hemodialysis.
Contributions to nephrology 1983;36():133-8.